Cargando…

SARS-CoV-2 seroprevalence in oncology healthcare professionals and patients with cancer at a tertiary care centre during the COVID-19 pandemic

BACKGROUND: During the COVID-19 outbreak, healthcare professionals (HCP) are at the frontline of clinical management and at increased risk for infection. The SARS-CoV-2 seroprevalence of oncological HCP and their patients has significant implications for oncological care. METHODS: HCP and patients w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fuereder, Thorsten, Berghoff, Anna Sophie, Heller, Gerwin, Haslacher, Helmuth, Perkmann, Thomas, Strassl, Robert, Berger, Julia Maria, Puhr, Hannah Christina, Kreminger, Judith, Moik, Florian, Schubert, Lorenz, Starzer, Angelika Martina, Steindl, Ariane, Winkler, Stefan, Preusser, Matthias, Tobudic, Selma
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470513/ https://www.ncbi.nlm.nih.gov/pubmed/32878898 http://dx.doi.org/10.1136/esmoopen-2020-000889

Ejemplares similares

Third dose of SARS-CoV-2 vaccination in hemato-oncological patients and health care workers: immune responses and adverse events – a retrospective cohort study
por: Mair, Maximilian J., et al.
Publicado: (2022)

Prophylactic treatment with oral azithromycin in cancer patients during the COVID-19 pandemic (OnCoVID): a randomized, single-blinded, placebo-controlled phase 2 trial
por: Mair, Maximilian J., et al.
Publicado: (2023)

Systemic inflammation scores correlate with survival prognosis in patients with newly diagnosed brain metastases
por: Starzer, Angelika M., et al.
Publicado: (2021)

DNA methylation profiles differ in responders versus non-responders to anti-PD-1 immune checkpoint inhibitors in patients with advanced and metastatic head and neck squamous cell carcinoma
por: Starzer, Angelika Martina, et al.
Publicado: (2022)

Immune escape mechanisms and therapeutic approaches in cancer: the cancer-immunity cycle
por: Starzer, Angelika M., et al.
Publicado: (2022)

Enhanced SARS-CoV-2 breakthrough infections in patients with hematologic and solid cancers due to Omicron
por: Mair, Maximilian J., et al.
Publicado: (2022)

Immunogenicity of COVID-19 Vaccinations in Hematological Patients: 6-Month Follow-Up and Evaluation of a 3rd Vaccination
por: Schubert, Lorenz, et al.
Publicado: (2022)

Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial
por: Bartsch, Rupert, et al.
Publicado: (2022)

Renal Abscess: A Rare Complication of Paratyphoid Fever in an Immunocompetent Traveler from Southeast Asia
por: Schubert, Lorenz, et al.
Publicado: (2021)

Immune Response after mRNA COVID-19 Vaccination in Lung Transplant Recipients: A 6-Month Follow-Up
por: Tobudic, Selma, et al.
Publicado: (2022)

Precision medicine biomarkers in brain metastases: applications, discordances, and obstacles
por: Steindl, Ariane, et al.
Publicado: (2021)

SARS-CoV-2 Vaccine Response in Patients With Autoimmune Hepatitis
por: Schneider, Lisa, et al.
Publicado: (2022)

New emerging targets in cancer immunotherapy: CD27 (TNFRSF7)
por: Starzer, Angelika M., et al.
Publicado: (2020)

1692P SARS-CoV-2 RNA testing in cancer patients treated at a Department of Medical Oncology in Vienna, Austria
por: Berghoff, A.S., et al.
Publicado: (2020)

Nachwuchsförderung durch die European Society for Medical Oncology (ESMO): Erfahrungen aus dem ESMO Young Oncologist Committee (YOC)
por: Oing, Christoph, et al.
Publicado: (2020)

Gemcitabine and Platinum-Based Agents for the Prediction of Cancer-Associated Venous Thromboembolism: Results from the Vienna Cancer and Thrombosis Study
por: Moik, Florian, et al.
Publicado: (2020)

A Longitudinal Seroprevalence Study Evaluating Infection Control and Prevention Strategies at a Large Tertiary Care Center with Low COVID-19 Incidence
por: Schubert, Lorenz, et al.
Publicado: (2021)

The accelerated waning of immunity and reduced effect of booster in patients treated with bDMARD and tsDMARD after SARS-CoV-2 mRNA vaccination
por: Tobudic, Selma, et al.
Publicado: (2023)

Surveillance of respiratory syncytial virus infections in adults, Austria, 2017 to 2019
por: Schubert, Lorenz, et al.
Publicado: (2021)

Thyroid Hormone Replacement Therapy Is Associated with Longer Overall Survival in Patients with Resectable Gastroesophageal Cancer: A Retrospective Single-Center Analysis
por: Puhr, Hannah C., et al.
Publicado: (2021)

EVI1 Promotes the Proliferation and Invasive Properties of Human Head and Neck Squamous Cell Carcinoma Cells
por: Grandits, Alexander Michael, et al.
Publicado: (2022)

Favourable outcome of patients with breast cancer brain metastases treated with dual HER2 blockade of trastuzumab and pertuzumab
por: Bergen, Elisabeth Sophie, et al.
Publicado: (2021)

Tumor DNA methylation profiles correlate with response to anti-PD-1 immune checkpoint inhibitor monotherapy in sarcoma patients
por: Starzer, Angelika M, et al.
Publicado: (2021)

Breakthrough infections with SARS-CoV-2 omicron efficiently boost antibodies from previous BNT162b2 vaccinations
por: Perkmann, Thomas, et al.
Publicado: (2023)

The usefulness of CYFRA 21–1 to diagnose and predict preeclampsia: a nested case-control study
por: Kuessel, Lorenz, et al.
Publicado: (2016)

Serum antibody response to BNT162b2 after natural SARS‐CoV‐2 infection
por: Perkmann, Thomas, et al.
Publicado: (2021)

Clinical characteristics, treatment, and long-term outcome of patients with brain metastases from thyroid cancer
por: Wolff, Ladislaia, et al.
Publicado: (2023)

Elevated Free Thyroxine Levels Are Associated with Poorer Overall Survival in Patients with Gastroesophageal Cancer: A Retrospective Single Center Analysis
por: Puhr, H. C., et al.
Publicado: (2019)

SARS-CoV-2 screening in cancer outpatients during the second wave of the COVID-19 pandemic: Conclusions for crisis response at a high-volume oncology center
por: Berger, Julia M., et al.
Publicado: (2021)

Anti-Spike Protein Assays to Determine SARS-CoV-2 Antibody Levels: a Head-to-Head Comparison of Five Quantitative Assays
por: Perkmann, Thomas, et al.
Publicado: (2021)

Initial SARS-CoV-2 vaccination response can predict booster response for BNT162b2 but not for AZD1222
por: Perkmann, Thomas, et al.
Publicado: (2021)

Bone turnover markers can predict healing time in medication-related osteonecrosis of the jaw
por: Schubert, Lorenz, et al.
Publicado: (2021)

Evaluation of the Septifast M(Grade) Test on Standard Care Wards—A Cohort Study
por: Ratzinger, Franz, et al.
Publicado: (2016)

Usage Data and Scientific Impact of the Prospectively Established Fluid Bioresources at the Hospital-Based MedUni Wien Biobank
por: Haslacher, Helmuth, et al.
Publicado: (2018)

Machine learning for fast identification of bacteraemia in SIRS patients treated on standard care wards: a cohort study
por: Ratzinger, Franz, et al.
Publicado: (2018)

Clinical risk factors for ascites in metastatic pancreatic cancer
por: Berger, J.M., et al.
Publicado: (2023)

Metal drugs become targeted
por: Fuereder, Thorsten, et al.
Publicado: (2017)

Testing lupus anticoagulants in a real-life scenario - a retrospective cohort study
por: Ratzinger, Franz, et al.
Publicado: (2017)

Sarcopenia in Neurological Patients: Standard Values for Temporal Muscle Thickness and Muscle Strength Evaluation
por: Steindl, Ariane, et al.
Publicado: (2020)

Viennese risk prediction score for Advanced Gastroesophageal carcinoma based on Alarm Symptoms (VAGAS score): characterisation of alarm symptoms in advanced gastro-oesophageal cancer and its correlation with outcome
por: Puhr, Hannah Christina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_03vgkdlf606ocjrqkl6ht1ad8l